Vidac Pharma Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $9M
Latest Deal Amount
  • Investors
  • 4

Vidac Pharma General Information

Description

Developer of anti-cancer drugs designed to treat patients with oncologic and dermatologic diseases. The company's drugs are a master regulator of metabolism in proliferating cells that is absent from most normal cells, enable doctors to monitor patients' metabolic pathways through VDAC/HK2 modulators.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 10 Hartom Street
  • 2nd floor, Har Hotzvim
  • Jerusalem 9777510
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vidac Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 29-Jun-2016 $9M 000 Completed Clinical Trials - Phase 2
1. Early Stage VC Completed Startup
To view Vidac Pharma’s complete valuation and funding history, request access »

Vidac Pharma Executive Team (4)

Name Title Board Seat Contact Info
Paul Salama Ph.D Vice President of Chemistry, Manufacturing and Control
Chaim Brickman MD Chief Medical Officer
Max Herzberg Ph.D Founder, Chief Executive Officer & Chairman
To view Vidac Pharma’s complete executive team members history, request access »

Vidac Pharma Board Members (8)

Name Representing Role Since
Christian Policard Vidac Pharma Board Member 000 0000
Max Herzberg Ph.D Self Founder, Chief Executive Officer & Chairman 000 0000
Oren Becker Ph.D Vidac Pharma Board Member 000 0000
Robert Spiegel MD Self Board Member 000 0000
Yochai Richter Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Vidac Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vidac Pharma Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ed Saltzman Angel (individual) Minority 000 0000 000000 0
Israel Biotech Fund Venture Capital Minority 000 0000 000000 0
Mivtach Shamir Holdings PE/Buyout Minority 000 0000 000000 0
Robert Spiegel Angel (individual) Minority 000 0000 000000 0
To view Vidac Pharma’s complete investors history, request access »